
TopNews Arab Emirates
<img alt="" height="1" width="1" />
FDA delays decision on breast cancer drug Avastin
BusinessWeek
Drugmaker Roche says US health regulators have delayed a decision on whether to expand approval of its drug Avastin for breast cancer, a use that has generated vigorous debate among cancer specialists and patients. The FDA granted Avastin accelerated ...
Roche Effort to Expand Avastin in Breast Cancer Delayed by US RegulatorsBloomberg
Why The Avastin Breast Cancer Controversy? Roche's Own News Release Tells YouForbes (blog)
Looming ruling on breast cancer drug splits patient advocatesCNN
FiercePharma -MarketWatch (press release) -Xinhua
all 148 news articles »
More...